We are live on
!
Find out more
P
Pitcairn Portfolio holdings
AUM
$1.27B
1-Year Est. Return
23.64%
This Fund
S&P 500
This Quarter
Est. Return
+4.52%
1 Year Est. Return
+23.64%
3 Year Est. Return
+111.21%
5 Year Est. Return
+126.49%
10 Year Est. Return
+390.83%
AUM
$833M
AUM Growth
+$7.36M
(+0.89%)
Cap. Flow
-$24.9M
Cap. Flow
% of AUM
-2.99%
Top 10 Holdings %
Top 10 Hldgs %
52.45%
Holding
520
New
34
Increased
100
Reduced
321
Closed
48
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$3.57M |
| 2 |
Intuit
INTU
|
+$2.04M |
| 3 |
Cadence Design Systems
CDNS
|
+$1.21M |
| 4 |
Gilead Sciences
GILD
|
+$1.12M |
| 5 |
Steel Dynamics
STLD
|
+$778K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$3.05M |
| 2 |
NXP Semiconductors
NXPI
|
+$2.76M |
| 3 |
Akamai
AKAM
|
+$1.93M |
| 4 |
TE Connectivity
TEL
|
+$1.92M |
| 5 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$1.85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 24.59% |
| 2 | Financials | 10.12% |
| 3 | Technology | 8.57% |
| 4 | Healthcare | 7.38% |
| 5 | Consumer Discretionary | 5.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BEAT
401
DELISTED
BioTelemetry, Inc.
BEAT
| $241K | 0.03% |
7,192
-252
| -3% | -$7.52K |
|
402
Hasbro
HAS
$12.6B
| $240K | 0.03% |
2,154
-187
| -8% | -$19.3K |
|
|
MCRN
403
DELISTED
Milacron Holdings Corp.
MCRN
| $234K | 0.03% |
13,292
+452
| +4% | +$8.1K |
|
|
CXO
404
DELISTED
CONCHO RESOURCES INC.
CXO
| $233K | 0.03% |
1,919
-6
| -0.3% | -$758 |
|
405
Ligand Pharmaceuticals
LGND
$6.1B
| $232K | 0.03% |
3,060
-127
| -4% | -$8.88K |
|
406
Allient
ALNT
$1.5B
| $231K | 0.03% |
+12,740
| New | +$210K |
|
407
Keysight
KEYS
$56B
| $231K | 0.03% |
5,942
-11
| -0.2% | -$415 |
|
408
Edison International
EIX
$30.9B
| $230K | 0.03% |
2,942
-18
| -0.6% | -$1.44K |
|
409
James River Group Holdings
JRVR
$209M
| $230K | 0.03% |
5,797
-225
| -4% | -$9.21K |
|
|
PX
410
DELISTED
Praxair Inc
PX
| $230K | 0.03% |
1,737
-79
| -4% | -$10.1K |
|
411
WEC Energy
WEC
$37B
| $229K | 0.03% |
3,736
-1
| -0% | -$62 |
|
412
DigitalBridge
DBRG
$2.92B
| $227K | 0.03% |
4,025
-796
| -17% | -$43.2K |
|
413
Caesarstone
CSTE
$76.8M
| $226K | 0.03% |
6,443
-1,063
| -14% | -$39.9K |
|
414
Foster
FSTR
$442M
| $226K | 0.03% |
+10,516
| New | +$178K |
|
415
Parker-Hannifin
PH
$122B
| $226K | 0.03% |
1,410
-18
| -1% | -$2.85K |
|
416
Renasant Corp
RNST
$4B
| $226K | 0.03% |
5,171
-349
| -6% | -$14.6K |
|
417
Western Alliance Bancorporation
WAL
$9.11B
| $226K | 0.03% |
4,589
-115
| -2% | -$5.47K |
|
|
WPX
418
DELISTED
WPX Energy, Inc.
WPX
| $226K | 0.03% |
23,403
+2,060
| +10% | +$23.5K |
|
|
XLNX
419
DELISTED
Xilinx Inc
XLNX
| $225K | 0.03% |
+3,497
| New | +$221K |
|
420
DXC Technology
DXC
$1.53B
| $223K | 0.03% |
+3,360
| New | +$223K |
|
|
CLR
421
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $222K | 0.03% |
6,874
-223
| -3% | -$8.82K |
|
|
BSFT
422
DELISTED
BroadSoft, Inc.
BSFT
| $222K | 0.03% |
+5,152
| New | +$202K |
|
423
Kulicke & Soffa
KLIC
$5.53B
| $220K | 0.03% |
+11,586
| New | +$244K |
|
424
Southwest Gas
SWX
$6.72B
| $220K | 0.03% |
3,023
-39
| -1% | -$3.12K |
|
|
MBFI
425
DELISTED
MB Financial Corp
MBFI
| $220K | 0.03% |
+4,998
| New | +$213K |
|
Similar funds
SFI
WCWM
BA
SAM
4CM
SIMG
HT
BCM
Pitcairn's Q2 2017 Portfolio in Review
As of Q2 2017, Pitcairn held 520 positions worth $833M, up 0.89% from $825M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Pitcairn's Q2 2017 filing shows 34 new, 100 increased, 321 reduced and 48 closed positions. Its largest new stake was Zoetis: 60,519 shares worth $3.77M. The largest sale was LyondellBasell Industries, an estimated $3.05M.
By sector, the portfolio is most concentrated in Consumer Staples at 25% of assets, up from 24% a quarter earlier, followed by Financials and Technology.
- Pitcairn's largest Q2 2017 buy was Zoetis: 60,519 shares worth $3.77M.
- Pitcairn added most to Intuit in Q2 2017, an estimated $2.04M increase.
- Pitcairn's biggest Q2 2017 reduction was Alexion Pharmaceuticals, cutting an estimated $1.54M.
- Pitcairn fully exited LyondellBasell Industries in Q2 2017, selling an estimated $3.05M.
- Pitcairn's ten largest holdings make up 52% of its $833M portfolio in Q2 2017.
- Pitcairn opened 34 new positions and closed 48 in Q2 2017.
- Pitcairn's portfolio value rose 0.89% quarter-over-quarter to $833M.
Based on Pitcairn's 13F filing for Q2 2017, filed 2 Aug 2017.